Notre Dame
Claris GenomiX Seeks Commercialization Partners for Cancer Subtyping Tests, Starting With CRC
Premium
The University of Notre Dame spinout has developed molecular subtyping tests for colorectal and other cancers, and seeks partners to bring them to the clinic.
Notre Dame Team Wins $2.9M NIH Grant for ExRNA Analysis Platform
The platform is designed to isolate exosomes from blood, then release their extracellular RNA cargo for analysis as biomarkers for diseases including cancer.
Team Sequences Mosquito Genomes to Better Understand Malaria Parasite Transmission
An international team sequenced and analyzed the genomes of 16 Anopholes mosquito species to unravel evolutionary relationships and adaptations offering hints to malaria parasite transmission.
Transposagen Expands License to DNA Transposon Tech
Transposagen's expanded license with the University of Notre Dame, University of Florida, and the USDA will cover nearly all commercial applications, including as a tool for drug and biomarker discovery.
Lilly Readies Web Portal for PD2 Initiative; University of Cincinnati Joins List of Participants
Premium
Under the Phenotypic Drug Discovery program, researchers from academia or biotech submit candidate compounds in specific therapeutic areas for Lilly to evaluate and profile. Participating organizations retain full IP rights to the compounds, but Lilly receives first rights to negotiate a broader collaboration or licensing agreement.